Photo from Yüksel Ürün/LinkedIn
Apr 27, 2024, 10:00
Yüksel Ürün: How do experts agree on treating high-risk localized prostate cancer with clear evidence of T3 disease on MRI?
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared on X/Twitter:
“How do experts agree on treating high-risk localized prostate cancer with clear evidence of T3 disease on MRI?
In this case, there is a strong consensus (96% agreement) among experts to treat patients with localized prostate cancer who have clinically T2 (DRE positive) cN0 cM0 and ISUP ≥ 3 carcinoma and clear evidence of T3 disease on MRI as T3.”
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 12:41
Feb 21, 2025, 12:39
Feb 21, 2025, 11:36
Feb 21, 2025, 11:29